Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-06

Clinical Trial Update: A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

View source ↗

Summary

The study completed and posted results evaluating IL-6 and IL-6/sIL-6R complex levels in subjects with active inflammatory bowel disease to explore inflammatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Inflammatory Bowel Disease | Status: COMPLETED | Results posted: 2017-03-06